Furthermore,
Non-targeted analysis is an analytical approach that screens for all detectable chemical compounds in a sample simultaneously โ without requiring prior knowledge of what those compounds are. Unlike targeted methods, which measure only pre-selected analytes, Materials Metric applies non-targeted analysis to discover unknown, unexpected, or emerging contaminants across complex material matrices.
Moreover,
Modern manufacturing, regulatory compliance, and materials safety all demand a deeper understanding of chemical composition. Consequently, non-targeted analysis has become an essential tool for engineers, quality managers, and scientists who need comprehensive chemical intelligence โ not just a confirmation of known species.
Furthermore, regulatory frameworks such as ISO 10993-18 Chemical Characterization now explicitly require exhaustive chemical characterization of materials โ particularly for medical devices and implants. As a result, non-targeted analysis sits at the heart of modern compliance workflows.
Key Takeaways
- Non-targeted analysis detects all chemical compounds in a sample โ including unknowns โ without pre-selection of analytes.
- High-resolution mass spectrometry is the most powerful instrument platform for non-targeted analysis workflows.
- Regulatory standards like ISO 10993-18 and USP guidance increasingly require non-targeted screening for medical devices and pharmaceutical materials.
- Non-targeted methods complement targeted methods; together, they deliver the most complete chemical picture.
- Data interpretation and expert review are critical โ raw non-targeted datasets require skilled analysts to extract actionable results.
- Materials Metric offers non-targeted analysis as part of its broader Chemical & Analytical Testing portfolio.
Non-targeted analysis: An analytical strategy that uses high-sensitivity instrumentation โ typically high-resolution mass spectrometry โ to detect and identify all measurable chemical entities in a sample simultaneously, without restricting measurement to a pre-defined list of target compounds.
Key fact: Non-targeted analysis is widely recognized as one of the most comprehensive chemical screening strategies available, capable of detecting hundreds to thousands of compounds in a single analytical run.
What Is Non-Targeted Analysis and Why Does It Matter?
In addition,
Non-targeted analysis is a hypothesis-free screening method. Instead of asking “is compound X present?”, analysts ask “what compounds are present?” This fundamental shift in question unlocks chemical discovery that targeted panels simply cannot provide.
Moreover, many real-world contamination events involve compounds that nobody anticipated. However, residual solvents, process degradation products, leachables from packaging, and environmental contaminants all fall into this category. Consequently, a targeted panel will miss them entirely.
How Non-Targeted Analysis Differs from Targeted Analysis
Therefore,
Targeted analysis measures a fixed, pre-defined list of analytes. Consequently, analysts know exactly what they are looking for, and the instrument parameters are optimized for those specific compounds. This approach delivers high sensitivity and quantitative precision for known analytes.
By contrast, non-targeted analysis casts a much wider net. As a result, instruments collect data across a broad mass range, capturing signals from every detectable species simultaneously. However, this breadth comes with a data interpretation challenge โ the resulting datasets are enormous.
In addition, targeted methods cannot detect what they were not designed to detect. Specifically, non-targeted workflows fill that gap. For instance, an unexpected degradation product or a novel process-related impurity would appear in a non-targeted screen but remain invisible to a standard targeted assay.
When Should You Choose Non-Targeted Analysis?
Notably,
Several scenarios make non-targeted analysis the clear choice. Specifically, it excels in situations where the chemical identity of contaminants or impurities is unknown. Similarly, it is ideal during early-stage material characterization, where the full chemical composition of a new substance has not been established.
Furthermore, regulatory submissions for medical devices, pharmaceuticals, and food-contact materials often require comprehensive chemical characterization. In these contexts, non-targeted analysis provides the breadth of coverage that regulators expect. Teams conducting FDA chemical characterization reviews regularly rely on non-targeted workflows to satisfy agency expectations.
Additionally, non-targeted analysis supports failure investigations and root-cause analysis. When a product fails a safety test or receives a customer complaint about an unexpected odor, taste, or effect, non-targeted screening rapidly identifies candidate culprits.
Quick note: Non-targeted analysis does not replace targeted analysis. Rather, it complements it. The most robust analytical programs use non-targeted screening to discover unknowns, then develop targeted methods to confirm and quantify them.
What Instruments and Techniques Power Non-Targeted Analysis?
Non-targeted analysis depends on high-resolution, broad-spectrum instrumentation. The most powerful platforms combine separation techniques with high-resolution mass spectrometry (HRMS). Together, these tools provide both the chemical separation and the mass accuracy needed to identify unknown compounds.
Moreover, each instrument platform has distinct strengths. Understanding which tool best fits your sample matrix and analytical objective is essential for obtaining actionable results.
High-Resolution Mass Spectrometry: The Core Engine
High-resolution mass spectrometry (HRMS) is the dominant technology in non-targeted analysis. Instruments such as Orbitrap and time-of-flight (TOF) mass spectrometers measure exact molecular masses with sub-ppm accuracy. This precision allows analysts to calculate molecular formulas and search spectral databases for compound identification.
Furthermore, modern HRMS instruments record full-spectrum data โ meaning every ion detected across the full scan range is stored. Consequently, analysts can retrospectively search archived data for new compounds, even months after the original analysis.
In particular, coupling HRMS with liquid chromatography (LC-HRMS) or gas chromatography (GC-HRMS) dramatically improves compound identification. Chromatographic separation reduces spectral complexity, making it far easier to resolve co-eluting compounds and assign correct identities.
Complementary Spectroscopic Tools for Non-Targeted Workflows
Mass spectrometry alone does not always provide a definitive compound identification. Therefore, analysts often combine HRMS results with complementary spectroscopic techniques to confirm structures.
For organic compound identification, NMR Spectroscopy provides detailed structural information about molecular connectivity. Similarly, FTIR Analysis and Raman Spectroscopy offer functional group information that helps narrow down candidate structures.
For inorganic and elemental unknowns, techniques such as XRF Analysis and XPS Analysis complement organic HRMS workflows. Notably, XPS provides surface-specific elemental and chemical-state data โ invaluable for understanding surface contamination and leachable species from solid materials.
Chromatographic Separation Platforms
The choice of chromatographic platform significantly shapes non-targeted analysis outcomes. GC-MS Analysis excels at detecting volatile and semi-volatile organic compounds. Meanwhile, HPLC Analysis covers a broader polarity range and handles thermally labile compounds that GC cannot analyze.
In practice, a comprehensive non-targeted analysis program often deploys both GC-MS and LC-MS to achieve maximum chemical coverage. For example, a material intended for medical use might require both platforms to characterize volatile residuals and non-volatile extractables simultaneously. This is especially relevant in extraction conditions studies, where solvent polarity and temperature drive which compound classes are captured.
| Technique | Best For | Key Strength | Typical Coverage |
|---|---|---|---|
| GC-HRMS | Volatiles, semi-volatiles | Excellent library matching | Organic, non-polar |
| LC-HRMS | Non-volatile organics, polar compounds | Broad polarity range | Organic, polar & non-polar |
| NMR Spectroscopy | Structural confirmation | Definitive structure elucidation | Organic compounds |
| XRF / ICP-MS | Elemental unknowns | Multi-element screening | Inorganic / elemental |
| FTIR / Raman | Functional group ID | Non-destructive screening | Organic & inorganic |
How Does Non-Targeted Analysis Work? The Step-by-Step Workflow
Non-targeted analysis follows a structured workflow โ from sample preparation through data acquisition to compound identification and reporting. Each stage requires careful planning and expert execution. Mistakes at any point can propagate through the entire analysis and compromise results.
Moreover, the workflow for non-targeted analysis differs significantly from targeted method execution. Teams planning their first non-targeted study often underestimate the importance of data processing and interpretation compared to instrument acquisition time.
Stage 1 โ Sample Preparation and Extraction
Effective sample preparation is the foundation of any successful non-targeted analysis. The goal is to extract the broadest possible range of compounds from the sample matrix without introducing artifacts or bias. Solvent choice, extraction temperature, and agitation conditions all influence which compounds are captured.
For solid materials, exhaustive extraction protocols are commonly applied. Detailed guidance on this approach appears in our article on exhaustive extraction methods. In essence, multiple solvents spanning a range of polarities โ such as hexane, acetonitrile, and water โ are used sequentially to maximize compound recovery.
Furthermore, analysts must consider the extraction conditions carefully. Temperature, contact time, and solvent-to-sample ratios all matter. Teams seeking deeper guidance on optimizing these parameters can review our dedicated resource on extraction conditions.
Stage 2 โ Instrument Data Acquisition
Once the extract is ready, the sample enters the instrument platform. In non-targeted analysis, the instrument records data across the full detectable mass range โ not just at pre-programmed ion transitions as in targeted assays. This generates very large data files, often gigabytes in size per sample.
Modern HRMS instruments also acquire MS/MS (tandem mass spectrometry) data automatically using data-independent acquisition (DIA) or data-dependent acquisition (DDA) modes. Consequently, analysts obtain both precursor ion masses and fragmentation spectra, which are essential for compound identification. This is a significant advantage over lower-resolution instruments.
Additionally, instrument calibration and quality control samples are critical. Analysts include internal standards, blanks, and reference materials in each analytical run. These controls verify instrument performance and help distinguish true sample signals from background noise or contamination artifacts.
Stage 3 โ Data Processing and Compound Identification
Raw mass spectrometry data must be processed before any compound identification can occur. Specialized software โ such as MZmine, XCMS, or vendor-specific platforms โ performs peak detection, alignment, and deconvolution across all samples. This step converts raw instrument files into a structured feature list.
Subsequently, each detected feature is searched against chemical databases such as PubChem, ChemSpider, or NIST. Exact mass, isotope patterns, and MS/MS fragmentation spectra all inform the confidence level of each identification. Analysts work through a tiered identification system, ranging from confirmed standards to tentatively identified compounds.
Notably, not every detected feature will yield a confident identification. Many compounds remain as “unknowns” โ detected but not yet matched to a reference structure. This is a normal outcome in non-targeted analysis and an active area of research. Resources such as Nature Reviews Methods Primers and ScienceDirect – Analytical Methods regularly publish advances in this area.
Furthermore, expert human review remains indispensable at this stage. Automated software tools identify candidate compounds, but a skilled analytical chemist must evaluate each hit for chemical plausibility, spectral quality, and relevance to the sample matrix. Teams requiring support with this process can benefit from Scientific & Technical Consulting services.
For novel or structurally unusual compounds, additional structural confirmation may involve unknown compound identification workflows. These workflows combine multiple orthogonal techniques โ NMR, FTIR, and mass spectrometry โ to establish unambiguous molecular identity. Such rigorous identification supports regulatory submissions and safety assessments with high confidence.
Non-Targeted Analysis Applications Across Key Industries
Non-targeted analysis serves a remarkably broad range of industries. Each sector brings unique sample types, regulatory requirements, and risk profiles. Understanding how non-targeted workflows apply in your specific field helps teams plan more effective analytical programs.
Moreover, the consequences of undetected chemical impurities vary significantly by industry. In medical devices, unknown leachables can trigger toxicological risk. In aerospace, unexpected material degradation products can compromise structural integrity.
Pharmaceutical and Drug Product Applications
In pharmaceutical development, non-targeted analysis identifies unknown degradation products, process-related impurities, and extractables from packaging components. Regulatory agencies expect manufacturers to characterize these species thoroughly. Furthermore, non-targeted screening supports impurity profiling during formulation development and stability studies.
Pharmaceutical teams also apply non-targeted analysis to raw material qualification. Consequently, unexpected adulterants or contamination events are caught before they reach finished drug products. Our Chemical Purity & Contaminant Screening services support exactly these pharmaceutical workflows.
Medical Device Chemical Characterization
Medical device manufacturers face some of the most demanding non-targeted analysis requirements. ISO 10993-18 requires a structured chemical characterization process that explicitly calls for non-targeted screening to identify extractables and leachables from device materials.
Specifically, devices that contact blood, tissue, or bodily fluids must undergo thorough chemical characterization before regulatory submission. Non-targeted analysis discovers unexpected leachables that targeted panels cannot anticipate. These findings then feed into Biocompatibility & Toxicity Testing assessments to determine whether detected compounds pose a patient safety risk.
Additionally, novel biomaterials and polymer formulations introduce complex leachable profiles. Non-targeted workflows characterize these materials comprehensively, reducing the risk of late-stage regulatory surprises.
Environmental and Food Contact Materials
Environmental monitoring represents another critical application area. Regulatory agencies worldwide require broad screening of water, soil, and air samples for emerging contaminants โ many of which are unknown at the time of analysis. Non-targeted analysis identifies these novel environmental pollutants before targeted methods even exist for them.
Similarly, food contact materials must undergo chemical migration testing. Packaging films, coatings, and adhesives can release hundreds of compounds into food products. Non-targeted screening maps these migration profiles comprehensively. Teams can review relevant elemental guidance through USP Elemental Impurities resources for additional context on regulatory thresholds.
Aerospace and Advanced Materials
Aerospace engineers apply non-targeted analysis to understand the chemical composition of advanced composites, coatings, and adhesives. Outgassing studies, for example, require broad chemical screening to identify all volatile species released under vacuum or elevated temperature conditions.
Furthermore, failure investigations in aerospace frequently involve unknown chemical species โ stress corrosion byproducts, thermal degradation products, or contamination from maintenance chemicals. Non-targeted analysis rapidly generates a comprehensive chemical inventory that guides root-cause analysis. Our Chemical & Elemental Characterization services support these demanding aerospace programs.
Elemental Non-Targeted Analysis: ICP-MS, ICP-OES, and Beyond
Non-targeted analysis is not limited to organic compound discovery. Elemental screening โ identifying unknown inorganic species, trace metals, and elemental impurities โ follows a parallel non-targeted logic. Instruments such as ICP-MS and ICP-OES scan the full periodic table, detecting all measurable elements simultaneously.
Notably, this elemental non-targeted approach is central to regulatory compliance in both pharmaceutical and medical device contexts. Teams can explore the full scope of elemental testing through our Chemical & Elemental Characterization service pages.
ICP-MS for Trace Elemental Screening
Inductively coupled plasma mass spectrometry (ICP-MS) provides exceptional sensitivity for elemental analysis. Instruments detect elements across the entire periodic table at concentrations reaching parts per trillion. Consequently, ICP-MS serves as the premier tool for non-targeted elemental screening in pharmaceutical, medical device, and environmental samples.
For pharmaceutical applications, USP Elemental Impurities guidance sets permitted daily exposures for 24 elemental impurities. However, a non-targeted ICP-MS scan covers far more elements than this defined list โ revealing unexpected metals from process equipment, raw materials, or environmental contamination.
In addition, ICP-MS paired with chromatographic separation (speciation analysis) identifies not just which elements are present, but which chemical forms they take. Arsenic speciation, for example, distinguishes highly toxic inorganic arsenic from less toxic organic forms. This level of chemical detail is impossible with bulk elemental analysis alone.
ICP-OES and Complementary Elemental Tools
ICP-OES (inductively coupled plasma optical emission spectrometry) complements ICP-MS by providing excellent sensitivity for major and minor elements at higher concentration ranges. Teams frequently deploy both instruments in tandem to achieve optimal detection limits across all elements of interest.
Furthermore, techniques such as XRF Analysis offer rapid, non-destructive elemental screening of solid materials. Meanwhile, XPS Analysis provides surface-specific elemental information at nanometer depth resolution. Together, these tools form a powerful suite for comprehensive elemental non-targeted analysis.
| Technique | Detection Limit | Sample Type | Key Advantage |
|---|---|---|---|
| ICP-MS | Parts per trillion (ppt) | Liquids, digests | Ultratrace sensitivity, full periodic table |
| ICP-OES | Parts per billion (ppb) | Liquids, digests | Wide linear range, robust for high matrices |
| XRF | Parts per million (ppm) | Solids, liquids | Non-destructive, rapid screening |
| XPS | 0.1 atomic % | Solid surfaces | Surface-specific chemical state information |
Quality Assurance and Best Practices in Non-Targeted Analysis
Producing reliable non-targeted analysis results requires rigorous quality assurance at every stage. Unlike targeted methods, non-targeted workflows lack the same level of standardized validation frameworks. Therefore, laboratories must apply structured best practices to ensure data integrity and defensible results.
Furthermore, regulatory submissions based on non-targeted data receive intense scrutiny. Consequently, laboratories must document their methods, controls, and data interpretation decisions thoroughly.
Method Development and Validation Considerations
Non-targeted analysis methods require careful development before sample analysis begins. Extraction protocols, instrument parameters, and data processing workflows must all be optimized for the specific sample matrix and regulatory context. Our Method Development & Validation services guide teams through this critical process.
Importantly, non-targeted methods cannot be validated in the same way as targeted assays. Instead, laboratories demonstrate fitness-for-purpose through performance qualification experiments. These include recovery studies using representative spiked standards, sensitivity assessments, and repeatability evaluations across multiple analytical runs.
Additionally, inter-laboratory reproducibility is an emerging area of focus. As non-targeted analysis becomes more widely adopted in regulatory submissions, harmonized quality standards are increasingly important. Resources published through ScienceDirect document current best practices and evolving consensus approaches in this space.
Data Quality Controls and Traceability
Every non-targeted analytical run must include a structured set of quality controls. Procedural blanks detect background contamination introduced during sample preparation. Solvent blanks monitor instrument background. Matrix-matched reference materials verify extraction efficiency and instrument response.
Moreover, internal standards โ ideally isotopically labeled analogs of representative compounds โ track instrument performance and correct for matrix effects. These controls are non-negotiable in any defensible non-targeted analysis program. Without them, distinguishing real sample signals from laboratory artifacts becomes extremely difficult.
Traceability of all raw data, processing parameters, and identification decisions must be maintained throughout. Many regulatory submissions require full audit trails demonstrating that data have not been selectively processed or filtered. Our Chemical & Analytical Testing team applies these rigorous standards on every non-targeted project.
Expert Review and Reporting Standards
Raw non-targeted datasets require expert interpretation before they become actionable. Automated software generates candidate compound lists, but human expertise must filter false positives, assess identification confidence, and prioritize compounds for further investigation.
Skilled analysts evaluate each candidate against chemical plausibility, spectral quality scores, and sample context. Consequently, the final report reflects both the analytical data and expert scientific judgment. For teams that need guidance navigating complex datasets, our Scientific & Technical Consulting services provide exactly this level of expert analytical support.
Furthermore, reporting for non-targeted analysis should follow tiered identification confidence frameworks. These frameworks โ widely adopted from the metabolomics community โ assign identification levels from confirmed reference standard matches down to tentatively assigned structures. Clear reporting of confidence levels helps regulators and safety assessors interpret results appropriately.
Frequently Asked Questions About Non-Targeted Analysis
What is the difference between non-targeted and suspect screening analysis?
Non-targeted analysis screens for all detectable compounds with no prior compound list. Suspect screening, by contrast, targets a list of plausible candidate compounds โ typically hundreds to thousands โ without confirmed reference standards. Both approaches use HRMS data. However, non-targeted analysis is the broadest strategy, while suspect screening sits between fully targeted and fully non-targeted workflows.
How long does a non-targeted analysis project typically take?
Project timelines vary significantly based on sample complexity, number of samples, and data interpretation requirements. Simple screening projects may complete in two to four weeks. Comprehensive regulatory-grade studies โ involving multiple extraction solvents, multiple instrument platforms, and detailed expert review โ often require eight to twelve weeks or longer. Early engagement with your laboratory helps set realistic timelines and scope expectations.
Can non-targeted analysis quantify compounds, or only identify them?
Non-targeted analysis primarily delivers qualitative and semi-quantitative results. Instruments collect data across a broad mass range without compound-specific calibration. Therefore, true quantification requires a targeted follow-up method with reference standards. However, semi-quantitative estimates using surrogate standards provide useful concentration ranges for risk assessment purposes, particularly in early-stage screening work.
Is non-targeted analysis required by regulatory agencies?
Regulatory requirements for non-targeted analysis are increasing. ISO 10993-18 explicitly calls for non-targeted chemical characterization of medical device materials. Similarly, FDA guidance on extractables and leachables for pharmaceutical packaging expects comprehensive chemical profiling beyond fixed targeted panels. Environmental regulators in multiple jurisdictions are also adopting non-targeted screening for emerging contaminant monitoring programs.
What sample types are compatible with non-targeted analysis?
Non-targeted analysis accommodates an exceptionally broad range of sample types. Solids, liquids, gases, extracts, biological matrices, polymers, metals, coatings, and environmental samples all fall within scope. Furthermore, the specific extraction and preparation strategy is tailored to each matrix. Consulting with an expert team early in project planning ensures the chosen approach maximizes chemical coverage for your specific material type.
How does non-targeted analysis support safety and toxicological risk assessment?
Non-targeted analysis delivers the compound inventory that toxicologists need to conduct a thorough risk assessment. Identified compounds are assessed against toxicological databases, structure-activity relationship models, and regulatory threshold guidance. Consequently, unknown compounds that pose a potential safety risk are flagged for further investigation or risk characterization. This workflow directly supports Biocompatibility & Toxicity Testing programs for medical devices, pharmaceuticals, and consumer products.
Conclusion
Non-targeted analysis represents one of the most powerful tools available to analytical scientists, quality managers, and regulatory professionals today. By detecting and identifying the full chemical inventory of a sample โ including unknowns โ it delivers chemical intelligence that targeted methods simply cannot provide.
Moreover, regulatory expectations continue to evolve toward more comprehensive chemical characterization. Teams that invest in non-targeted analysis workflows now are better positioned to meet current and future requirements. Importantly, non-targeted analysis is not a single technique โ it is a multi-platform, expert-driven strategy that integrates chromatography, high-resolution mass spectrometry, spectroscopy, and skilled data interpretation.
Furthermore, the value of non-targeted analysis extends well beyond regulatory compliance. It supports failure investigations, raw material qualification, formulation development, environmental monitoring, and materials safety assessment across virtually every industry. Each of these applications benefits from a laboratory partner with deep expertise in both instrumentation and data interpretation.
At Materials Metric, our team combines advanced analytical instrumentation with specialist scientific expertise across the full non-targeted analysis workflow. From extraction development through expert data review and regulatory reporting, we provide the comprehensive support that complex non-targeted projects demand. Our services span Chemical & Analytical Testing, Method Development & Validation, Biocompatibility & Toxicity Testing, and Scientific & Technical Consulting โ all integrated to support your most demanding analytical challenges.
If you are ready to discuss a non-targeted analysis project, our experts are available to help you scope the work, select the right analytical platforms, and design a study that meets your technical and regulatory objectives. Contact Materials Metric today to speak with a specialist and get your project started.
Related Posts from Materials Metric
Explore more insights from our team of materials scientists and analytical experts:
